Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
m&a
national blog main
national top stories
2019
activism
acute hepatic porphyria
alnylam pharmaceuticals
archive
bernie sanders
biopharma
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
congress
crisis
deals
detroit blog main
detroit top stories
drug prices
duchenne
easl
europe blog main
europe top stories
fatty liver disease
fda
givosiran
house of representatives
indiana blog main
indiana top stories
indivior
insulin
intercept pharmaceuticals
What
approval
3
×
gene
3
×
therapy
3
×
disease
drug
fda
treat
administration
advanced
alnylam’s
approves
betting
bff
billion
bio
biopharma
called
children
conference
deal
deals
designed
devoted
duchenne
easl
food
form
genetic
historic
infants
issued
kicked
liver
major
medicine
puts
race
rar
rare
recently
Language
unset
Current search:
therapy
×
approval
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More